Edaravone prevents neurotoxicity of mutant L166P DJ-1 in Parkinson's disease.

Abstract excerpt

Parkinson's disease (PD), which is estimated to affect approximately 1 % of the population over the age of 65, is the second most common neurodegenerative disorder after Alzheimer's disease. It was reported that pathogenic mutations in DJ-1 lead to autosomal recessive early-onset familial Parkins...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Free Radical Scavengers
• Share to Mitochondria
• Share to Oncogene Proteins